Transcription of HIV-1 at sites of intact latent provirus integration
Journal of Experimental Medicine · 2024
DOI: 10.1084/jem.20240391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Ana Rafaela Teixeira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA. Hauptthemen laut MEDLINE: HIV-1, Proviruses, Virus Latency, Virus Integration. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Einstein-Rockefeller-CUNY Center for AIDS Research, Stavros Niarchos Foundation.
Abstract (Originalsprache)
HIV-1 antiretroviral therapy is highly effective but fails to eliminate a reservoir of latent proviruses, leading to a requirement for life-long treatment. How the site of integration of authentic intact latent proviruses might impact their own or neighboring gene expression or reservoir dynamics is poorly understood. Here, we report on proviral and neighboring gene transcription at sites of intact latent HIV-1 integration in cultured T cells obtained directly from people living with HIV, as well as engineered primary T cells and cell lines. Proviral gene expression was correlated to the level of endogenous gene expression under resting but not activated conditions. Notably, latent proviral promoters were 100–10,000× less active than in productively infected cells and had little or no measurable impact on neighboring gene expression under resting or activated conditions. Thus, the site of integration has a dominant effect on the transcriptional activity of intact HIV-1 proviruses in the latent reservoir, thereby influencing cytopathic effects and proviral immune evasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
- Tessera Therapeutics , Somerville, MA, USA.
- Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
- Department of Infectious Diseases, Medical Faculty Heidelberg, Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg University, Heidelberg, Germany.
- Department of Infectious Diseases, Virology, Chica and Heinz Schaller (CHS) Research Group, University Hospital Heidelberg, Heidelberg, Germany.
- Howard Hughes Medical Institute , Chevy Chase, MD, USA.
ORCID-Profile: Ana Rafaela Teixeira, Cintia Bittar, Gabriela S Silva Santos, Thiago Y Oliveira, Amy S Huang, Noemi Linden, Isabella A T M Ferreira, Tetyana Murdza, Frauke Muecksch, R Brad Jones, Marina Caskey, Mila Jankovic, Michel C Nussenzweig
Förderung
- NIAID NIH HHS
- Einstein-Rockefeller-CUNY Center for AIDS Research
- Stavros Niarchos Foundation
- Rockefeller University
- NIH HHS
- National Institutes of Health
- REACH Delaney
- BEAT-HIV Delaney
Zitieren
APA
Teixeira, A. R., Bittar, C., Silva Santos, G. S., Oliveira, T. Y., Huang, A. S., Linden, N., Ferreira, I. A. T. M., Murdza, T., Muecksch, F., Jones, R. B., Caskey, M., Jankovic, M., & Nussenzweig, M. C. (2024). Transcription of HIV-1 at sites of intact latent provirus integration. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240391
Vancouver
Teixeira AR, Bittar C, Silva Santos GS, Oliveira TY, Huang AS, Linden N, et al. Transcription of HIV-1 at sites of intact latent provirus integration. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20240391
BibTeX
@article{Teixeira2024,
author = {Teixeira, Ana Rafaela and Bittar, Cintia and Silva Santos, Gabriela S and Oliveira, Thiago Y and Huang, Amy S and Linden, Noemi and Ferreira, Isabella A T M and Murdza, Tetyana and Muecksch, Frauke and Jones, R Brad and Caskey, Marina and Jankovic, Mila and Nussenzweig, Michel C},
title = {Transcription of HIV-1 at sites of intact latent provirus integration},
journal = {Journal of Experimental Medicine},
year = {2024},
doi = {10.1084/jem.20240391}
}
EUVIMED